| CAS No. | 192329-42-3 |
|---|---|
| MDL No. | N/A |
| MF | C18H21N3O5S2 |
| MW | 423.50 |
| InChI Key | YKPYIPVDTNNYCN-INIZCTEOSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 99.23% ; | $142 | In Stock | |
| 5 mg | 99.23% ; | $586 | In Stock | |
| 10 mg | 99.23% ; | $1097 | In Stock | |
| 25 mg | 99.23% ; | $1834 | In Stock | |
| 50 mg | 99.23% ; | $2472 | In Stock | |
| 100 mg | 99.23% ; | $3311 | In Stock | |
| 200 mg | 99.23% ; | $4475 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Prinomastat is a hydroxamic acid, specifically (3S)-N-hydroxy-2,2-dimethylthiomorpholine-3-carboxamide, in which the hydrogen on the thiomorpholine nitrogen is replaced by a [4-(pyridin-4-yloxy)phenyl]sulfonyl group. It is a selective inhibitor of MMPs 2, 3, 9, 13, and 14. It functions as an antineoplastic agent, a matrix metalloproteinase inhibitor, and an EC 3.4.24.35 (gelatinase B) inhibitor. It belongs to the classes of hydroxamic acids, thiomorpholines, sulfonamides, aromatic ethers, and pyridines. It is the conjugate base of prinomastat(1+).
| CAS No. | 192329-42-3 |
|---|---|
| Product Name | Prinomastat |
| Heavy Atom Count | 28 | Rotatable Bond Count | 5 |
| Atom Stereo Count | 1 | Bond Stereo Count | 0 |
| HBA | 7 | HBD | 2 |
| TPSA | 108.830 Ų | Charge | 0 |
| Exact Mass | 423.09226 | Complexity | 933.45 |
| pKa | 7.130 | XLogP | 2.264 |
